跳至主要内容
临床试验/NCT03729011
NCT03729011已完成4 期

Delirium Reduction by Volatile Anesthesia in Cardiac Surgery: Prospective, Randomized, Single-blinded Study

Meshalkin Research Institute of Pathology of Circulation5 个研究点 分布在 1 个国家目标入组 405 人开始时间: 2019年1月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
405
试验地点
5
主要终点
Postoperative delirium

研究概览

简要总结

Parallel group, prospective, randomized, controlled, single-blinded trial. The aim of our study is to test the hypothesis that volatile anesthesia would reduce the incidence of early postoperative delirium in patients undergoing cardiac surgery with CPB as compared to TIVA.

详细描述

Delirium is a common neurologic complication after cardiac surgery. Up to 52% of postoperative cardiac surgery patients have delirium. The occurrence of postoperative delirium is associated with worse outcomes, including prolonged length of stay in the ICU and hospital, increased morbidity and mortality, compromised long-term cognitive function and physical ability, and elevated medical care costs. Morbidity of postoperative cognitive dysfunction and delirium mostly common in patients with age more than 60 years.

Several factors including cerebral anoxia, embolism, excessive excitatory neurotransmitter release, systemic inflammatory response, electrolyte and metabolic disorders and hemodynamic changes have been demonstrated to contribute to postoperative neurological dysfunction and delirium.

Previous studies have shown that inhalation anaesthesia and total intravenous anaesthesia (TIVA) may produce different degrees of cerebral protection in these patients. Effects of this two types of anaesthesia in cardiac surgery with CPB remain controversial and much debated.

Inhalation agents depress glucose metabolism, decrease cerebral metabolic rate and oxygen consumption. They also partially uncouple the reactivity of cerebral blood flow to CO2. The changes in cerebral blood flow (CBF) depend on the changes in cerebral metabolism and on direct vasodilatory effects. Cerebral autoregulation is dose-dependently altered. Volatile anaesthetics have been shown to initiate early ischemic preconditioning in neurons, but models of focal brain ischemia suggest it can take 24 h for preconditioning to develop fully.

Propofol is a well-known potentiator of GABAA receptors, it reduces cerebrovascular resistance, CBF and cerebral oxygen delivery during cardiopulmonary bypass. A neuroprotective effect of propofol has been shown to be present in many in vitro and in vivo established experimental models of mild/moderate acute cerebral ischemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females > 65 years
  • Written informed consent
  • Cardiac surgery with CPB

排除标准

  • Emergency surgery
  • Surgery on aorta
  • Known allergy to components of anaesthesia
  • Pregnancy
  • Hemodynamically significant stenosis of carotid arteries
  • Parkinson's disease
  • Liver cirrhosis (Child B or C)
  • Current enrollment into another RCT (in the last 30 days)
  • Previous enrollment and randomization into the DELICATE trial
  • Poor language comprehension
  • Preoperative Medications: Anticholinergics (dimedrol, atropine, dramina), antidepressants, antiepileptics, antiparkinson drugs, chemotherapeutic agents

研究组 & 干预措施

Volatile anesthesia group

Active Comparator

干预措施: Volatile agent (Drug)

TIVA group

Active Comparator

干预措施: Propofol (Drug)

结局指标

主要结局

Postoperative delirium

时间窗: 5 days after surgery

Postoperative delirium detection will be managed with Confusion Assessment Method for the ICU (CAM-ICU)

次要结局

  • Myocardial infarction (MI)(30 days)
  • One-year all-cause mortality(1 year)
  • Early postoperative cognitive dysfunction(7 days after surgery)
  • Delirium duration(10 days after surgery)
  • Duration of ICU stay(30 days)
  • Duration of hospital stay(60 days)
  • 30-day all-cause mortality(30 days)
  • Stroke(30 days)
  • Seizures(30 days)
  • Incidence of acute kidney injury (AKI)(30 days)
  • Renal replacement therapy(30 days)
  • Infectious complications(30 days)
  • Pain assessment with Behavioral Pain Scale (BPS)(5 days after surgery)
  • Pain assessment with Numerical Rating Scale (NRS)(5 days after surgery)

研究者

发起方
Meshalkin Research Institute of Pathology of Circulation
申办方类型
Network
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验